Molecular structure of Rivastigmine hydrogen tartrate, CAS Number: 129101-54-8
Rivastigmine hydrogen tartrate (CAS 129101-54-8)
Alternate Names:
Exelon; Rivastigmine; Rivastigmine Tartrate
Application:
Rivastigmine hydrogen tartrate is a parasympathomimetic or cholinergic agent
CAS Number:
129101-54-8
Purity:
≥98%
Molecular Weight:
400.42
Molecular Formula:
C14H22N2O2•C4H6O6
Supplemental Information:
This is classified as a Dangerous Good for transport and may be subject to additional shipping charges.
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.
QUICK LINKS
Ordering Information
Description
Technical Information
Safety Information
SDS & Certificate of Analysis
Rivastigmine hydrogen tartrate is a parasympathomimetic or cholinergic agent. Rivastigmine hydrogen tartrate is also a dual ChEI (cholinesterase inhibitor); inhibiting BChE (butyrylcholinesterase) and AChE (acetylcholinesterase).
Rivastigmine hydrogen tartrate (CAS 129101-54-8) References
- Use of rivastigmine transdermal patch in the treatment of Alzheimer's disease. | Winblad, B. and Machado, JC. 2008. Expert Opin Drug Deliv. 5: 1377-86. PMID: 19040398
- Development of a novel dry powder inhalation formulation for the delivery of rivastigmine hydrogen tartrate. | Simon, A., et al. 2016. Int J Pharm. 501: 124-38. PMID: 26836711
- Mesoporous silica nanoparticles for efficient rivastigmine hydrogen tartrate delivery into SY5Y cells. | Karimzadeh, M., et al. 2017. Drug Dev Ind Pharm. 43: 628-636. PMID: 28043167
- Preparation and optimization of rivastigmine-loaded tocopherol succinate-based solid lipid nanoparticles. | Malekpour-Galogahi, F., et al. 2018. J Liposome Res. 28: 226-235. PMID: 28670949
- Thermosensitive in situ nanocomposite of rivastigmine hydrogen tartrate as an intranasal delivery system: Development, characterization, ex vivo permeation and cellular studies. | Salatin, S., et al. 2017. Colloids Surf B Biointerfaces. 159: 629-638. PMID: 28865359
- A Stability Indicating HPLC Assay Method for Analysis of Rivastigmine Hydrogen Tartrate in Dual-Ligand Nanoparticle Formulation Matrices and Cell Transport Medium. | Huda, NH., et al. 2018. J Anal Methods Chem. 2018: 1841937. PMID: 29686925
- Effects of rivastigmine hydrogen tartrate and donepezil hydrochloride on the cognitive function and mental behavior of patients with Alzheimer's disease. | Zhang, X., et al. 2020. Exp Ther Med. 20: 1789-1795. PMID: 32742410
- The effect of single and repeated doses of rivastigmine on gastric myoelectric activity in experimental pigs. | Tsianou, CC., et al. 2023. PLoS One. 18: e0286386. PMID: 37262057
- ApoE3 Anchored Liposomal Delivery of Rivastigmine for Brain Delivery: Formulation, Characterization, and In Vivo Pharmacokinetic Evaluation. | Khairnar, P., et al. 2023. AAPS PharmSciTech. 24: 223. PMID: 37945928
- Development and validation of high-performance liquid chromatography method for the simultaneous quantification of rivastigmine hydrogen tartrate and asiaticoside co-loaded in niosomes: A Box-Behnken design approach. | Hnin, HM., et al. 2024. J Chromatogr B Analyt Technol Biomed Life Sci. 1241: 124170. PMID: 38805871
Inhibitor of:
Choactase.Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Rivastigmine hydrogen tartrate, 100 mg | sc-204883 | 100 mg | $152.00 | |||
Rivastigmine hydrogen tartrate, 250 mg | sc-204883A | 250 mg | $300.00 |